Tweet
<img alt="" height="1" width="1" />
Curis Sinks as FDA Puts Partial Hold on Cancer Medicine
Bloomberg
Curis Inc. (CRIS), a developer of cancer medicines, fell the most in more than three years after U.S. regulators placed a partial hold on a trial of its drug for solid tumors after a patient died from liver failure. Curis dropped 21 percent to $3.08 at 10:16 a.m. New ...
Curis cancer drug put on partial hold after patient deathReuters
Curis Reports Third Quarter 2013 Financial Results and Provides CUDC-427 ...Wall Street Journal
Curis Shares Tumble As Cancer Drug Slapped With FDA Clinical HoldXconomy
FierceBiotech
all 12 news articles »
More...